发明名称 Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
摘要 Discloses use of an isolated antibody or antigen-binding fragment thereof that specifically binds to semaphorin-4D in the preparation of a medicament for alleviation of symptoms in a subject having, or suspected of having, Huntington’s disease (HD).
申请公布号 NZ630892(A) 申请公布日期 2016.03.31
申请号 NZ20140630892 申请日期 2014.09.11
申请人 VACCINEX INC. 发明人 SMITH ERNEST S.;ZAUDERER MAURICE;BOWERS WILLIAM J;JONASON ALAN
分类号 A61K39/395;A61K38/00;A61K38/02;A61P25/00 主分类号 A61K39/395
代理机构 代理人
主权项
地址